[News Brief] Legend Biotech to Present LB2501 Data at EHA 2026
Legend Biotech Corporation has announced that it will present preliminary Phase 1 clinical data for its investigational LB2501 therapy during…
Global Pharmaceuticals & Supplements
[News Brief] CordenPharma Agrees to Acquire AmbioPharm
CordenPharma has entered into an agreement to acquire AmbioPharm, a US-headquartered contract development and manufacturing organisation (CDMO), to expand its…
[News Brief] Australia Approves OncoSil™ Device for Pancreatic Cancer
Australia’s Therapeutic Goods Administration (TGA) has approved the OncoSil™ medical device for use in patients with locally advanced pancreatic cancer.…
[News Brief] AstraZeneca Enters Licensing Agreement with CSPC Pharmaceuticals
AstraZeneca has entered into a strategic collaboration with CSPC Pharmaceutical Group to obtain ex-China rights to a weight management portfolio…
[News Brief] GSK Enters Strategic Collaboration with SBP Group
GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsidiary Chia Tai Tianqing…
[News Brief] Amplexd Therapeutics Starts Phase 2 HPV Trial
Amplexd Therapeutics has received authorisation from the Hong Kong Department of Health to begin a Phase 2 trial of an…
[News Brief] Griffith University and Thermo Fisher Sign MoU for Research Collaboration
Griffith University and Thermo Fisher Scientific have signed a five-year Memorandum of Understanding (MoU) to support collaboration in health, biotechnology…
[News Brief] WHO Prequalifies First Malaria Treatment for Newborns
The World Health Organization has prequalified Coartem Baby (artemether-lumefantrine), the first malaria treatment specifically developed for newborns and young infants…
[News Brief] Cirrus Therapeutics Expands to Singapore with R&D Site
Cirrus Therapeutics has expanded into Singapore with a new R&D site and formed a partnership with A*STAR to advance ophthalmic…
[News Brief] ImmunoScape Signs MoU for US Cancer Clinical Trial
ImmunoScape has signed a Memorandum of Understanding with a US-based cancer centre to launch an investigator-initiated clinical trial targeting WT1-positive…